vimarsana.com

Page 11 - கூட்டாட்சியின் பத்திரங்கள் சட்டங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against XL Fleet Corp (XL)

NEW YORK, March 09, 2021 (GLOBE NEWSWIRE) Gainey McKenna & Egleston announces that a class action lawsuit has been filed against XL Fleet Corp. (“XL Fleet”) (NYSE: XL) in the United States District Court for the Southern District of New York on behalf of those who purchased or acquired the securities of XL Fleet between October 2, 2020 and March 2, 2021, inclusive (the “Class Period”). The lawsuit seeks to recover damages for investors under the federal securities laws. The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) XL Fleet’s salespeople were pressured to inflate their sales pipelines to boost the Company’s reported sales and backlog; (2) at least 18 of the 33 customers that XL Fleet featured were inactive and had not placed an order since 2019; (3) XL Fleet’s technology had been materially overstated and offered only 5% to 10% of fleet savings; (4) XL Fleet lacks

LAWSUIT FILED: Leidos Holdings, Inc Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP

BOSTON, MA / ACCESSWIRE / March 5, 2021 / Block & Leviton LLP (www.com), a national securities litigation firm, announces that a lawsuit for violations of the federal securities laws has been filed against Leidos Holdings, Inc.

ONTRAK ALERT: Bragar Eagel & Squire, P C Is Investigating Ontrak, Inc on Behalf of Ontrak Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ontrak, Inc. (NASDAQ: OTRK) on behalf of Ontrak stockholders. Our investigation concerns whether Ontrak has violated the federal securities laws and/or engaged in other unlawful business practices.

FIVE PRIME ALERT: Bragar Eagel & Squire, P C Investigates Sale of FPRX and Encourages Investors to Contact the Firm

NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Five Prime Therapeutics, Inc. (NASDAQ: FPRX) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Amgen Inc. (NASDAQ: AMGN). Click here to learn more and participate in the action. On March 4, 2021, Five Prime announced that it had signed an agreement to be acquired by Amgen for approximately $1.9 billion. Pursuant to the merger agreement, Five Prime stockholders will receive $38 in cash for each share of Five Prime common stock owned. The deal is scheduled to close in the second quarter of 2021. Bragar Eagel & Squire is concerned that Five Prime’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.